Baylor College of Medicine: KIPA Potentially Predicts Chemotherapy Response in Triple Negative Breast Cancer
July 21, 2023
July 21, 2023
HOUSTON, Texas, July 21 (TNSjou) -- The Baylor College of Medicine issued the following news:
Researchers at Baylor College of Medicine and collaborating institutions are developing a strategy to predict the response of triple negative breast cancer (TNBC) to chemotherapy, which would be a valuable tool for physicians deciding on the treatment with better probability of success on an individual basis. The study appears in Cancer Research Communications, a journal of the American Ass . . .
Researchers at Baylor College of Medicine and collaborating institutions are developing a strategy to predict the response of triple negative breast cancer (TNBC) to chemotherapy, which would be a valuable tool for physicians deciding on the treatment with better probability of success on an individual basis. The study appears in Cancer Research Communications, a journal of the American Ass . . .